3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Point-of-Care Diagnostics: An Overview
5. Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
5.1.3 Government Initiatives
5.1.4 Technological Advancements
5.1.5 Rising FDA Approvals
5.1.6 Lack of Skilled Lab Personnel
5.1.7 Rising Awareness about POCT
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Lack of Regulatory Standards
5.2.3 Data Management & Connectivity
5.3 Market Opportunities
5.3.1 Physical Robotic Telepresence
5.3.2 Smart Virtual Assistant in Association with Mobile Devices
8. Point-of-Care Testing Market, By Region
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
8.1.4 Rest of the World
9. Industry Trends and Developments
9.1 Portable Ultrasound Providing Care on Site
9.2 Microfluidics Technology Crowding the POCT Industry
10. Company Profiles
10.1 Becton, Dickinson and Company
10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Abbott Laboratories
10.6 Johnson & Johnson
10.7 OraSure Technologies, Inc.
10.8 Thermo Fisher Scientific Inc.
10.9 Medtronic plc